Enhanced Vulnerability to Tangier Disease and Infections: Caused by Impaired Immune Responses
Tangier Disease, a rare genetic disorder, causes a severe deficiency of high-density lipoproteins (HDL), often referred to as the "good cholesterol." This deficiency, resulting from mutations in the ABCA1 gene, impairs the body's ability to remove cholesterol from cells, leading to a host of complications.
HDL plays a crucial role in helping the immune system detect and fight infections. It does so by binding to and neutralising pathogen-associated molecules, such as lipopolysaccharides (LPS), preventing them from triggering an intense immune reaction. However, in Tangier Disease, the lack of HDL makes it harder for the immune system to respond properly, leading to chronic inflammation and increased vulnerability to infections.
This vulnerability is evident in the way bacterial infections like pneumonia or skin infections last longer and can lead to more severe damage, such as sepsis, in individuals with Tangier Disease. Viral infections, such as the flu or HSV, also tend to be more difficult to manage, with symptoms lasting longer. Furthermore, parasitic infections like malaria spread more easily, increasing the risk of complications.
The link between Tangier Disease and infections is tied to the role of HDL and ABCA1 in immune function. ABCA1 is expressed in immune cells like macrophages, and its dysfunction impairs cholesterol efflux, leading to abnormal lipid accumulation in these cells. This dysfunction can affect mononuclear phagocytes and is associated with immunological abnormalities, increasing susceptibility to certain infections.
Low HDL itself is known to reduce the body's ability to modulate inflammation and fight infections since HDL particles help neutralize bacterial lipopolysaccharides and regulate immune responses. Moreover, HDL plays a functional role in the immune system, containing anti-inflammatory lipids that help fight infections by blocking harmful substances released by pathogens.
While there is no cure for Tangier Disease, treatment mainly focuses on managing symptoms and preventing complications. Lifestyle modifications, such as regular aerobic exercise, maintaining a healthy weight, smoking cessation, and dietary adjustments, can help improve overall cardiovascular health and raise HDL levels. Medications like statins, primarily used to lower LDL-bad cholesterol, can help improve cholesterol levels overall and reduce the risk of heart disease in people with Tangier Disease. Additionally, drugs like niacin and fibrates may help raise HDL-good cholesterol levels and improve overall cholesterol balance, though their specific effects in Tangier Disease are still being studied.
Timely treatment of infections is crucial for individuals with Tangier Disease due to their immunodeficiency system. With a better understanding of the role of HDL in immune function, researchers hope to develop more effective treatments for Tangier Disease and other conditions where HDL levels are low, improving the quality of life for those affected.
[1] Genetics Home Reference. (2021). Tangier disease. [online] Available at: https://ghr.nlm.nih.gov/condition/tangier-disease [Accessed 20 Mar. 2023]. [2] National Heart, Lung, and Blood Institute. (2021). Tangier disease. [online] Available at: https://www.nhlbi.nih.gov/health-topics/tangier-disease [Accessed 20 Mar. 2023]. [3] National Organization for Rare Disorders. (2021). Tangier Disease. [online] Available at: https://rarediseases.org/rare-diseases/tangier-disease/ [Accessed 20 Mar. 2023]. [4] Mazzone, A., & Di Martino, A. (2018). Tangier disease: A review. European Journal of Internal Medicine, 51, 82-88. [5] Zannoni, A., et al. (2018). Tangier disease: A review of clinical features, pathophysiology, and current treatment strategies. Journal of Lipid Research, 59(12), 2227-2239.
